Insider filing · SVRA

David A Ramsay bought $417K of Savara (SVRA)

Executed Mar 31 2025, disclosed Apr 1 2025, 1 day later.

Over the 21 trading sessions from the disclosed entry session (Apr 1 2025), the stock returned +9.6% (delay-adjusted); from the execution session (Mar 31 2025), +16.0%. Derived: entry at the session's open, exit at the close 20 sessions later.

DR David A Ramsay Director profile →

David A Ramsay (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Savara Inc. (SVRA). The largest single filing was $121K of SVRA (20,000 sh × $6.06, as filed), executed Dec 19 2025.

SVRA Savara Inc. SVRA · Healthcare · 5 filings in 24 months ticker →

Healthcare · Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→